Article

Ophthalmologists face several public policy issues, AAO official says

When the Centers for Medicare and Medicaid Services (CMS) publishes reports on the physicians who participate in the Physician Quality Reporting Initiative, patients may be suspicious of physicians who don?t participate, said William Rich III, MD, medical director of health policy, American Academy of Ophthalmology (AAO). He provided the perspective of the practitioner during a mini-symposium on glaucoma public policy.

When the Centers for Medicare and Medicaid Services (CMS) publishes reports onthe physicians who participate in the Physician Quality Reporting Initiative, patients may besuspicious of physicians who don't participate, said William Rich III, MD, medical director ofhealth policy, American Academy of Ophthalmology (AAO). He provided the perspective of thepractitioner during a mini-symposium on glaucoma public policy.

He also said that the transactional approach to health care, wherein a physician provides aservice and then is paid, is changing to a system that recognizes efficiency in care.

The drive for enhanced quality measures with an emphasis on outcomes is here to stay, Dr. Richsaid. Any system measuring quality and outcomes, however, be it in the public or privatesector, should recognize (in the case of eye care) that some ophthalmologists aresubspecialists for whom the majority of patients have more serious conditions than those seenby general ophthalmologists or optometrists. Not all systems have this ability right now, headded.

"We have to get consumer groups involved," Dr. Rich said.

The public policy issues related to glaucoma that Dr. Rich addressed included the use ofeconomic profiling, the overvaluation of services, the search for a new fix for the sustainablegrowth rate, the increased scrutiny of new devices, and relations with industry. On the latterpoint, Dr. Rich said, ophthalmologists should examine their individual relationships withindustry. Pressure to report the receipt of meals, drug samples, pens, and the like, isincreasing, he said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.